Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study

SIMPLE SUMMARY: The treatment of resectable gastric and gastroesophageal junction adenocarcinomas is enhanced by a strategy of perioperative chemotherapy (CT) when compared with surgery alone. But, there is still a need for new approaches to further improve outcomes in patients treated with perioper...

Descripción completa

Detalles Bibliográficos
Autores principales: Gronnier, Caroline, Mariette, Christophe, Lepage, Come, Monterymard, Carole, Jary, Marine, Ferru, Aurélie, Baconnier, Mathieu, Adhoute, Xavier, Tavan, David, Perrier, Hervé, Guerin-Meyer, Véronique, Lecaille, Cédric, Bonichon-Lamichhane, Nathalie, Pillon, Didier, Cojocarasu, Oana, Egreteau, Joëlle, D’journo, Xavier Benoit, Dahan, Laétitia, Locher, Christophe, Texereau, Patrick, Collet, Denis, Michel, Pierre, Ben Abdelghani, Meher, Guimbaud, Rosine, Muller, Marie, Bouché, Olivier, Piessen, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093434/
https://www.ncbi.nlm.nih.gov/pubmed/37046849
http://dx.doi.org/10.3390/cancers15072188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093434/
https://www.ncbi.nlm.nih.gov/pubmed/37046849
http://dx.doi.org/10.3390/cancers15072188

Ejemplares similares